7 analysts have expressed a variety of opinions on CG Oncology (NASDAQ:CGON) over the past quarter, offering a diverse set of opinions from bullish to bearish.

The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

Analysts have set 12-month price targets for CG Oncology, revealing an average target of $70.14, a high estimate of $75.00, and a low estimate of $60.00. Experiencing a 3.92% decline, the current average is now lower than the previous average price target of $73.00.

Investigating Analyst Ratings: An Elaborate Study

In examining recent analyst...